StockData
Elite Pharmaceuticals Inc logo

Elite Pharmaceuticals Inc (ELTP) KPIs and segments

ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 14/30
$0.25−0.00 (-1.37%)

Close on Oct 19, 2026Market cap $281.77MP/E 5.0Yield –

KPIs & segments

Operating metrics and segments that drive Elite Pharmaceuticals's business

Elite Pharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Elite Pharmaceuticals's fiscal year ends March 31 — Q1 FY27 = CQ2 2026 (calendar quarter).

Periods
Add to chartMetric
Q1 FY27
CQ2 2026
Q4 FY26
CQ1 2026
Q3 FY26
CQ4 2025
Q2 FY26
CQ3 2025
Q1 FY26
CQ2 2025
Q4 FY25
CQ1 2025
Q3 FY25
CQ4 2024
Q2 FY25
CQ3 2024
Q1 FY25
CQ2 2024
Q4 FY24
CQ1 2024
Q3 FY24
CQ4 2023
Q2 FY24
CQ3 2023
Abbreviated New Drug Applications($M)2
40.232.014.418.918.817.915.514.2
Manufacturing($M)
39.831.613.718.218.417.914.813.5
Licensing($M)
0.430.420.630.660.360.040.750.65
New Drug Applications($M)
0000000000
Manufacturing($M)
40.531.436.239.831.613.718.218.417.914.813.5
ANDA Revenue($M)
32.139.8
Scheduled Products Manufacturing Fees($M)
27.838.9
Direct Sales to Wholesalers($M)
16.419.0
Indirect Sales to Wholesalers($M)
15.720.7
Unscheduled Products Manufacturing Fees($M)
4.320.86
Unscheduled Products Licensing Fees($M)
0.43
Licensing($M)
0.220.300.210.130.430.420.630.660.360.040.750.65
Scheduled Products Licensing Fees($M)
0.22
Business Segment($M)
11.912.725.615.34.336.236.316.405.643.83
Abbreviated New Drug Applications($M)
11.912.725.615.34.336.236.316.405.643.83
Earlier reporting (last reported 2023)1

15 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-08-13.

See a number that looks wrong?